Servier will acquire Day One Biopharmaceuticals for roughly $2.5 billion. But an analyst says other companies could make ...

Ruiz explained that Q1 Platform revenue is expected to "remain light with recovery coming gradually over the course of the year." He also forecasted "strong double-digit growth for each quarter of ...

The CRN 2026 Partner Program Guide takes a look at how partner programs changed over the last 12 months to incorporate or support the selling of AI solutions by channel Partners.

Selling, general, and administrative expenses were $23.9 million in the fourth quarter of 2025 versus $24.8 million in the fourth quarter of 2024. AerSale incurred $1.8 million of share-based ...

Grocery Outlet (NASDAQ:GO) executives struck a candid tone while reviewing fourth-quarter results and outlining a 2026 plan ...

A $7.5 million loss was recognized in 2025 due to a legacy litigation settlement, partially offsetting GAAP loss improvement.

A decade ago, more than 63% of the pharmaceutical giant's revenue was tied up in one drug -- Humira. Granted, it was the top-selling drug in the world at the time. But despite the 130 patents it ...

Vibativ, Sancuso, and new Talicia brand led revenue gains, with initial Talicia sales commencing in Q4. Balance Sheet ...

Blackstone Life Sciences will provide $400 million to support development of duvakitug, a human monoclonal antibody targeting ...

As USF marks its 70th anniversary, a new economic impact report estimates the university generates nearly $7 billion annually ...

Electrical supplies distributor Sonepar announced Oct. 8 that its Digital Job Center — an online project management platform used by contractors across the United States — has surpassed $2 billion in ...

Sturm, Ruger & Company, Inc. (NYSE:RGR) executives said the firearms market remained challenging in 2025, but emphasized that ...